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Scotopic Electroretinogram in Term Infants Born of
Mothers Supplemented with Docosahexaenoic Acid
during Pregnancy
Cari A. Malcolm,1 Ruth Hamilton,2 Daphne L. McCulloch,1 Colette Montgomery,3 and
Lawrence T. Weaver3
PURPOSE. To test the hypothesis that the supplementation of
the diets of pregnant women with a fish oil rich in docosa-
hexaenoic acid (DHA) enhances retinal development in their
healthy term infants, as measured during the early postnatal
period by the electroretinogram (ERG).
METHODS. One hundred pregnant women were randomized to
receive either a fish oil (n  50) or a placebo oleic acid dietary
supplement (n  50) from 15 weeks of pregnancy until deliv-
ery. Total fatty acids in red blood cells (RBCs) and plasma were
measured in mothers at 15 and 28 weeks of pregnancy and at
delivery and in their infants in umbilical cord blood. Infant
retinal development was assessed within the first week of life
with full-field ERGs that included a scotopic blue intensity
series (n  41) and a bright white flash (2.0 log cd-s/m2; n 
44).
RESULTS. Infants born of mothers who received supplements
did not differ at birth in weight, gestational age, or any other
standard variable. Infant DHA status at birth, as measured from
umbilical cord blood, did not differ significantly between ma-
ternal supplementation groups. ERG implicit times, ampli-
tudes, and parameters of the stimulus–response function did
not differ significantly between infants in the maternal supple-
mented and placebo groups. There was, however, a relation-
ship between infant DHA status and maturity of the retina at
birth, regardless of maternal supplementation group. A mea-
sure of retinal sensitivity (log ) correlated significantly (P 
0.005) with DHA status (as a percentage of total fatty acid; TFA)
in infant cord blood. Infants in the highest quartile for cord
blood DHA had higher retinal sensitivity compared with infants
in the lowest quartile. Infants in the highest quartile for plasma
DHA, both as a percentage of TFA and concentration, were
born at a significantly later gestational age than were infants in
the lower quartiles.
CONCLUSIONS. These findings demonstrate an association be-
tween the DHA status of term infants and retinal sensitivity,
suggesting an essential role of this long-chain polyunsaturated
fatty acid (LCPUFA) in the development and function of the
retina. However, maternal DHA status was not significantly
associated with infant retinal sensitivity and no direct effect of
maternal supplementation was observed. (Invest Ophthalmol
Vis Sci. 2003;44:3685–3691) DOI:10.1167/iovs.02-0767
The highest concentration of docosahexaenoic acid (DHA)in the body is found in the outer segment membranes of
the photoreceptors,1,2 suggesting that this long-chain polyun-
saturated fatty acid (LCPUFA) plays essential structural and
functional roles within the human retina. During the last few
months of fetal life and the early months of postnatal life, large
quantities of DHA are deposited in the infant brain and ret-
ina.3,4 Because the photoreceptor outer segment membranes
are in a state of rapid growth during this period, the developing
retina has a particularly high DHA requirement and may be
vulnerable to deficiencies. With a limited ability to synthesize
this LCPUFA from its precursors, the infant relies on maternal
sources of DHA, prenatally through active transport across the
placenta and postnatally in breast milk.
Over the past few decades, adverse effects of reduced DHA
concentration on retinal function have been demonstrated in
studies conducted in both animals5–10 and humans.11,12 Most
of these studies have used the ERG to assess the effects of
postnatal DHA deficiency and/or supplementation on retinal
function. In a study of very-low-birth-weight (VLBW) and pre-
mature infants tested at 36 weeks of postconceptional age
(PCA), those infants receiving formulas without DHA demon-
strated significantly lower rod maximum amplitudes, lower
sensitivity, and higher thresholds than those infants receiving
DHA-supplemented formulas.11 Such findings suggest that the
maturity and sensitivity of the rod photoreceptors is delayed in
premature infants who receive diets low in DHA.11
Before the present study, the potential effects of supple-
menting maternal diets with DHA during pregnancy on the
development and maturation of the retina had not been exam-
ined. Increasing maternal DHA supply during pregnancy
through dietary supplementation may increase the amount of
DHA available to the developing infant.13,14 Subsequently, the
increased DHA level in the infant may contribute to improved
retinal and visual function. Therefore, the primary purpose of
our study was to test the hypothesis that the dietary supple-
mentation of pregnant women with fish oil rich in DHA en-
hances retinal function of their infants as measured by the ERG.
The effect of maternal supplementation on maternal and infant
DHA status, as reflected in maternal RBC and plasma and
umbilical cord RBCs and plasma, is summarized herein and will
be reported fully elsewhere.15,16
METHODS
Experimental Design and Subjects
This study was prospective, double-blind, randomized, and controlled
in design. It was performed in accordance with the Declaration of
Helsinki and approved by the Ethics Committee of Yorkhill NHS Trust
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(Glasgow, UK). One hundred healthy pregnant women were invited to
take part in the study while attending an antenatal clinic at approxi-
mately 15 weeks of pregnancy. Women with diabetes, twin pregnan-
cies, pre-eclampsic toxemia, a history of abruption or postpartum
hemorrhage, allergy to fish products, or a thrombophilic tendency or
those receiving drugs that affect thrombocyte function (nonsteroidal
anti-inflammatory drugs) were excluded. Written informed consent
was obtained from each study participant at the time of enrollment.
The pregnant women were randomized to either the treatment or
control group. Subjects in the treatment group (n  50) received
dietary supplementation with fish oil capsules rich in DHA (Marinol
D40; 100 mg of DHA per capsule; R. P. Scherer Ltd., Swindon, UK),
whereas subjects in the control group (n  50) received sunflower oil
placebo capsules from enrollment until the time of delivery. The
placebo capsules contained no traces of DHA or its precursor -linole-
nic acid (ALA). The fatty acid composition of the study capsules is
described in Table 1. The fish oil and placebo capsules were identical
in appearance and could not be distinguished by odor or taste. Subjects
in both groups were instructed to consume two study capsules per
day. Maternal diet, particularly the consumption of fish products, was
assessed by interview at 15 and 28 weeks of pregnancy and at delivery.
Healthy infants born after 36 weeks’ gestation, with an Apgar score
of greater than seven at 5 minutes and without any diagnosed visual,
medical, or developmental disorders were eligible to continue in the
postnatal phase of the study. Infant retinal function was assessed as
soon as possible after birth, but always within the first week of life,
using full-field electroretinograms (ERGs). Birth weight, length, and
occipital frontal head circumference (OFC) were measured within the
first 24 hours after delivery.
Fatty Acid Composition
Venous blood samples were obtained from the women at enrollment
(15 weeks of pregnancy), at 28 weeks of pregnancy, and at delivery.
Blood samples were also obtained from the umbilical cord at delivery.
Total fatty acids in plasma and red blood cells (RBCs) were extracted
by modified Folch extraction and derivatized with methanolic hydro-
chloric acid. Fatty acid methyl esters were analyzed by gas chromatog-
raphy mass spectrometry (GC-MS). The results were expressed in both
relative (percentage of total fatty acids, %TFA) and absolute (concen-
trations in nanomoles per milliliter) terms.
Electroretinography
ERG recordings were coordinated with the infants’ feeding patterns,
ideally after a feeding, when infants were most likely to be settled or
asleep. Before dark adaptation, the pupils were dilated with 1 drop of
0.5% cyclopentolate in each eye. Sterile, light-occluding adhesive
patches were applied, and the infant was allowed to dark adapt for a
minimum of 30 minutes. At the end of the dark adaptation period, the
infant was transferred to the recording room. All ERG recordings took
place in a side room of the neonatal unit in the Queen Mother’s
Hospital, Yorkhill NHS Trust (Glasgow, UK). The infant was swaddled
and placed supine on a specially made foam mattress inside an incu-
bator. The incubator had been modified with a customized aperture in
the cover to allow the Ganzfeld bowl (Ganzfeld Stimulator; LKC Sys-
tems Inc., Gaithersburg, MD) to be lowered and positioned directly
over the infant’s face. The distance from the viewing aperture of the
Ganzfeld bowl to the infant’s eyes was 8 to 10 cm, and the diameter of
the Ganzfeld bowl opening was 27 cm.
The infant’s forehead was cleansed with a skin preparation gel (Nu
Prep; D. O. Weaver and Co., Aurora, CO). Conductive paste (10-20;
D. O. Weaver and Co.) was applied to a silver-silver chloride disc
electrode, and the electrode was placed centrally on the forehead to
act as a ground. Under dim red light, the adhesive eye patches were
removed, and pupil dilatation with 1 drop of 0.5% cyclopentolate in
each eye was repeated. One drop of 0.5% proxymetacaine, to act as a
topical anesthetic, was instilled in the right eye. The recording elec-
trode, a bipolar Burian-Allen contact lens electrode, sized especially for
a small infant (Hansen Ophthalmic Department Laboratories, Iowa
City, IA), was filled with 1% carmellose sodium (Celluvisc; Allergan
Pharmaceuticals Ltd., Westport, Ireland) to act as a lubricant and
placed on the right cornea.
Stimuli were delivered into the Ganzfeld bowl by a photostimulator
(Grass PS33 Plus; Astro-Med Inc., West Warwick, RI) set at its maxi-
mum intensity. The signals were amplified and filtered by an amplifier
(Biodata PA400; Biodata, Manchester, UK) with a band-pass of 0.5 to
300 Hz and a gain of 5000. The amplified signals were then processed
in real time (averaging and artifact rejection) with custom-designed
software.17
An intensity-series ERG was performed to study rod photoreceptor
function. A series of calibrated neutral-density filters (Wratten; Eastman
Kodak, Herts, UK) mounted on a filter wheel and a blue filter were
used to record rod ERGs to progressively increasing flash brightness.
Ganzfeld luminance ranged from 4.475 log scot cd-s/m2 to 0.442 log
scot cd-s/m2 (peak wavelength, 475 nm) in 0.4-log unit steps. At higher
intensities, cone intrusion into the rod response can occur. For this
reason, the procedure was repeated using a photopically matched red
filter (peak wavelength, 650 nm), evoking mixed rod and cone ERGs,
and these responses were computer-subtracted from the responses to
blue flashes to achieve rod-only responses at higher troland levels.18
The photopic match was established by photometric calibration of the
filters and by matching of adult photopic ERG amplitudes to red and
blue stimuli.
In addition, an ERG was recorded under dark-adapted conditions to
a bright white flash (2.0 log cd-s/m2) to elicit a mixed rod and cone
TABLE 1. The Fatty Acid Composition of the Fish Oil and the High
Oleic Sunflower Oil Placebo Study Supplements*
Fatty Acid
Fish Oil
(Marinol D40)
High Oleic
Sunflower Oil
C14:0 3.7 —
C16:0 6.7 4.0
C16:1n-7 4.3 —
C18:0 2.4 5.0
C18:1n-9 15.6 81
C18:2n-6 1.2 7.2
C18:3n-3 0.8 —
C18:4 1.4 —
C20:0 0.1 —
C20:1 2.0 —
C20:5n-3 7.2 —
C22:1 2.7 —
C22:5n-6 4.1 —
C22:6n-3 40.4 —
Sum of all 92.6 97.2
Others 9.4 3.0
Data are percent of total fatty acids.
* Marinol D40.
TABLE 2. Confirmation of Equivalence of a Neonatal and an Adult
Troland by Comparison of PD and PND Ratios between Age Groups
Mean Dilated
Pupil Diameter
(mm)
Posterior
Nodal Distance
(mm)
Newborns 5.0 11.0*
Adults 8.0 16.7
Ratio 0.63 0.66
2-Month infants 5.2† 11.2†
Adults 7.2† 16.7†
Ratio 0.72† 0.67†
* Data from Isenberg et al., 1995.22
† Data from Brown et al., 1987.21 Pupils in this study were not
dilated, but were measured while fully dark adapted.
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signal, which matches the International Society for Clinical Electro-
physiology of Vision (ISCEV) standard maximum combined ERG.19
All calibrations were performed with an integrating radiometer
with either photopic or scotopic photometric filters (IL1700 Radiom-
eter; International Light Inc., Newburyport, MA).
The interstimulus interval was 5 seconds for dim flashes and 10
seconds for bright flashes, to allow full recovery of the b-wave ampli-
tude between flashes. Two to 30 ERGs were averaged at each intensity.
The infants were monitored with a dim red light, and the flashes were
triggered when the pupil was clearly visible within the contact lens
electrode. At the end of testing, pupil diameter was measured and
recorded in millimeters. The complete recording procedure, excluding
dark adaptation, lasted approximately 45 to 60 minutes.
Recordings were performed in 11 adults (ages, 26–41 years) with
an identical protocol, but with the adults sitting upright looking into
the Ganzfeld bowl and wearing an adult-sized Burian-Allen electrode.
The ERG waveform has two main components, a negative a-wave
followed by a positive b-wave. Amplitudes and implicit times of these
components were measured for each ERG according to methods de-
scribed in the ISCEV standards.19 The a-wave amplitude was measured
from the baseline to the a-wave trough, whereas the b-wave amplitude
was measured from the a-wave trough to the b-wave peak. Implicit
time of both the a- and b-waves was measured from the time of the
flash stimulus to the peak or trough of the response.
Rod photoreceptor function was examined by fitting the b-wave
amplitudes to the Naka-Rushton function20: V/Vmax  I
n/(In  n),
FIGURE 1. Flowchart showing the
number of mothers and infants re-
maining at each stage of investiga-
tion.
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where V  b-wave amplitude expressed in microvolts, I  retinal
illuminance energy in scotopic troland-seconds (scot td-s) and Vmax,
log , and n are the derived parameters. Vmax is the maximum ampli-
tude of the b-wave. Log , a measure of retinal sensitivity, is the flash
energy at which Vmax is half its maximum value. The exponent n
represents the slope of the curve and was constrained to equal 1. To
meet the criteria for analysis using the stimulus-response function, the
ERG intensity series had to be reliably recorded to a minimum of five
different light intensities. Goodness-of-fit was established using r2 val-
ues.
Flash brightness incident on the retina (retinal illuminance energy),
was expressed in scotopic troland-seconds (scot td-s) and calculated by
multiplying the Ganzfeld luminance energy (in candela-seconds per
square meter) by pupil diameter (in square millimeters). The equiva-
lence of an adult and a neonatal troland was confirmed by comparison
of the ratios of adult-to-infant pupil diameter (PD) and posterior nodal
distances (PNDs)21,22 (Table 2), which were sufficiently similar (0.63
and 0.66, respectively).
Statistical Analysis
Differences in intensity series ERG implicit times between groups were
determined by two-factor repeated-measures ANOVA, with maternal
supplementation group and retinal illuminance as the main factors.
Differences in parameters of the stimulus–response function (Vmax and
log ) between maternal supplementation groups were also deter-
mined by ANOVA. Linear regression analysis was performed to relate
infant RBC and plasma LCPUFA status, specifically DHA, arachidonic
acid (AA), total n-6 LCPUFAs, total n-3 LCPUFAs, and the n-6 to n-3
ratio, with the b-wave implicit times, parameters of the stimulus-
response function, and implicit times and amplitudes of the maximum
combined ERG. To examine the data for nonlinear associations, a
Kendall  test was performed to test for a rank correlation between the
Vmax or log  and LCPUFA quartiles, as measured from umbilical cord
blood. Potential confounding variables, such as birth weight, gender,
gestational age at birth and age (in hours) at time of testing were not
significantly related to any measures of the ERGs evaluated in this
study. Moreover, infants in the fish oil and placebo group did not differ
significantly in birth weight, gender, gestational age at birth, and age at
time of testing. Therefore, these variables were not included in the
regression models.
All statistical analyses were performed on computer (SPSS for
Windows, ver. 9.0; SPSS Inc., Chicago, IL).
RESULTS
Subjects
One hundred women were recruited into the study at approx-
imately 15 weeks of pregnancy (mean, 15.4 weeks or 109 days;
range, 104–119). At study entry, subjects in the fish oil and
placebo groups did not differ significantly in age, previous
obstetric history, socioeconomic status, smoking habits, alco-
hol intake, exercise patterns or dietary intake of fish. Moreover,
during the period between study entry and delivery, there
were no significant differences between the groups in maternal
dietary intake of fish or consumption of dietary supplements
containing DHA (P  0.31).
Figure 1 outlines the number of subjects remaining at each
stage of the study. At delivery, 63 mothers and their infants
remained in the study. One infant was withdrawn, because he
was born at less than 36 weeks’ gestation and two infants were
withdrawn because they had low Apgar scores (7 at 5 min-
utes) at delivery and subsequently required admission to the
special-care nursery for observation. Therefore, 60 infants, 31
in the fish oil and 29 in the placebo group were eligible to
continue in the study. There were no significant differences in
gestational length between the fish oil and placebo groups,
with a mean gestational age of 279.7  9.5 and 279.6 8.5
days (SD), respectively. Moreover, birth weight, length, OFC,
and the ratio of boys to girls were not significantly different
between infants in the fish oil and placebo groups (Table 3).
Gestational length, however, was significantly greater in in-
fants in the upper quartile for umbilical cord plasma DHA, both
as %TFA (P  0.005) and concentration (P  0.05) when
compared with infants in the lower quartiles (Table 4). Gesta-
tional length did not differ based on quartiles of umbilical cord
RBC DHA.
ERGs were recorded in 56 (93%) of the 60 study infants
shortly after birth (mean 53.9  27.1 hours). It was not possi-
ble to record ERGs from the remaining four infants because of
early discharge of mothers and infants from the hospital (n 
2), and withdrawal of consent for the ERG procedure (n  2).
Satisfactory ERG intensity series were obtained from 41 (73%)
of the 56 infants, 22 in the fish oil group and 19 in the placebo
group. In the remaining 15 infants, fewer than five data points
were obtained, and therefore they did not fulfill the criteria for
analysis using the stimulus–response function. A satisfactory fit
of the Naka-Rushton curves was evident with a median r2 of
0.83 (range, 0.56–0 0.99). Maximum combined ERGs in re-
sponse to a bright white flash were recorded in 44 (79%) of the
56 infants, 25 in the fish oil group and 19 in the placebo group.
Fatty Acid Composition in RBCs and Plasma
Baseline DHA status, measured at enrollment, was similar be-
tween mothers in the fish oil and placebo supplementation
groups. However, after receiving supplementation from ap-
proximately 15 weeks of pregnancy until delivery, the relative
(%TFA) and absolute (nanomoles per milliliter) amounts of
DHA in RBCs was elevated in maternal RBCs in the fish oil
group compared with the placebo group. At delivery, the
median relative and absolute levels of DHA in mothers who
received fish oil supplementation were 168.2 nmol/mL (range,
6.2 –305.3) and 3% TFA (range, 0.3%–5.0) compared with
118.9 nmol/mL (range, 17.3–225.8) and 2% TFA (range, 0.5%–
4.0) in the mothers who received the placebo. There were no
significant differences in umbilical cord blood DHA status be-
tween infants in the fish oil and placebo maternal supplemen-
tation groups. The median relative and absolute levels of DHA
in infants born of the fish oil–supplemented mothers were 221
TABLE 3. Characteristics of Infants in the Maternal Fish Oil and
Placebo Groups Eligible for ERG Studies
Characteristic
Fish Oil
(n  31)
Placebo
(n  29) P
Gestational age at birth (days) 279.7  9.5 279.6  8.5 0.96
Gender (male/female) 16/15 11/18 0.21
Birth weight (g) 3508  501 3645  495 0.29
Birth length (cm) 52.6  2.5 53.2  2.9 0.42
Birth OFC (cm) 34.8  1.4 34.9  1.5 0.86
Data are the mean  SD.
TABLE 4. Gestational Length in Days According to Umbilical Cord
Plasma DHA Quartiles
Umbilical Cord
Blood Quartiles
Plasma DHA
Concentration
nmol/mL
Plasma
DHA
(% TFA)
Quartile 1—low (n  13) 275.1  10.3 273.8  7.9
Quartile 2—medium 1 (n  14) 279.9  3.9 279.5  10.1
Quartile 3—medium 2 (n  14) 280.3  11.0 282.1  7.6
Quartile 4—high (n  13) 283.5  6.1 283.2  6.2
Data are the mean  SD.
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nmol/mL (range, 70–465) and 4.4% TFA (range, 1.7%–5.8%)
compared with 273 nmol/mL (range, 98–478) and 4.2% TFA
(range, 1.8%–6.2%) in infants born of mothers who received
the placebo.
Electroretinography
Intensity-Series ERG. Although a reproducible ERG inten-
sity series can be successfully recorded in infants shortly after
birth, according to procedures outlined in the international
standards,19 our results demonstrate the relative immaturity of
the dark-adapted ERG at term age. All infants had robust b-
waves for moderate or bright blue flashes. Cone intrusion was
seldom evident, and red flashes elicited only small ERGs for the
brighter flashes. The a-waves were small and once again evi-
dent only at the brighter flashes. A typical ERG intensity series
recorded from a female term infant in response to a series of
blue flashes and to the maximum white flash is illustrated in
Figure 2.
There were no significant differences between infants in
the fish oil and placebo groups in b-wave implicit times at any
brightness. Moreover, infant cord blood LCPUFA status did not
correlate significantly with b-wave implicit time.
The parameters of the Naka-Rushton function, Vmax (F 
2.5, df 1,39, P  0.12), and log  (F  0.62, df 1,39, P  0.44)
did not differ significantly between the fish oil and placebo
group (Table 5). The table also shows adult results. In all the
infants, regardless of maternal supplementation group, simple
linear regression analysis revealed significant correlations be-
tween log  and several measures of DHA status, specifically
the proportion (%TFA) of DHA in RBCs (r  0.40, df 1,36,
P  0.05), the total proportion of n-3 fatty acids in RBCs (r 
0.33, df 1,36, P  0.05), and the n-6 to n-3 LCPUFA ratio in
RBCs (r  0.36, df 1,36, P  0.05) of infant cord blood. A
similar trend toward negative correlation between log  and
AA (%TFA) in infant cord blood was observed (P  0.06).
Infant LCPUFA status did not correlate significantly with Vmax.
To establish the robustness of these results and test for
nonlinear associations, the Naka-Rushton parameters derived
from those infants with lower levels of DHA in their cord blood
were compared with those infants who had higher DHA status.
The distribution of DHA in RBCs and plasma (%TFA and con-
centration) was divided into quartiles (Table 6). A Kendall 
test was then performed to test for any rank correlation be-
tween the Naka-Rushton parameters and RBCs and plasma
DHA quartiles. As in the linear regression, higher retinal sensi-
tivity (lower log ) was significantly associated with higher
DHA levels as measured by quartiles of RBC DHA (%TFA;  
0.31, P 0.005; Fig. 3). This nonlinear analysis was repeated
for other fatty acids, specifically AA, total n-3 LCPUFAs, total
n-6 LCPUFAs, and the n-6 to n-3 ratio. Similar rank correlations
were observed between log  and the quartile levels of AA (
0.24, P 0.05) and the sum of n-3 LCPUFAs (0.24, P
0.05) in RBCs (%TFA).
Maximum Combined ERG. The implicit time of the a-
wave (F  1.69; P  0.2) and the b-wave (F  0.05; P  0.83)
and the amplitude of the a-wave (F  1.1; P  0.31) and the
FIGURE 2. Representative data: (A) scotopic intensity series recorded
from a female infant born at 41.6 weeks’ gestation and tested at 4 days
of age. Troland level (log scotopic troland-seconds) is indicated in the
small box to the right of the ERG signals. The top trace represents the
maximum combined ERG, and was not used for the Naka-Rushton
curve fitting. (B) The Naka-Rushton function, fit to the b-wave ampli-
tudes (Vmax) of the data.
TABLE 5. Naka-Rushton Parameters Derived from the Scotopic Intensity Series ERG for Infants in the
Fish Oil and Placebo Maternal Supplementation Groups
Parameter
Fish Oil
(n  22)
Placebo
(n  19) P
Adult Values
(n  11)
Vmax (V) 61.9  30.5 48.6  21.8 0.12 467.6  113.7
Log  (log scot trol s) 0.39  0.59 0.26  0.45 0.44 0.26  0.22
Data are the mean  SD.
TABLE 6. Quartiles for DHA in Umbilical Cord RBC for Those Infants
Who Had an Intensity Series ERG Analyzed
Umbilical Cord
Blood Quartiles
RBC Concentration
(nmol/mL)
RBC
(% TFA)
Quartile 1—low 141 (70–180) 3.4 (1.7–3.7)
Quartile 2—medium 1 209 (183–228) 4.1 (3.8–4.3)
Quartile 3—medium 2 286 (240–321) 4.5 (4.4–4.8)
Quartile 4—high 353 (323–478) 5.4 (5.1–5.8)
Data are median (range).
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b-wave (F  0.2; P  0.65) of the maximal combined ERG did
not differ significantly between supplementation groups. Lin-
ear regression analysis revealed no significant correlation be-
tween implicit times or amplitudes of the a- or b-waves of the
maximum combined ERG and infant DHA status at birth. ERGs
recorded in infants in the lowest quartile for umbilical cord
blood DHA were not distinguishable from the ERGs recorded
in those in the highest quartile.
DISCUSSION
The present study has demonstrated a positive relationship
between infant DHA status and the scotopic ERG. Specifically,
those infants with the highest DHA levels in RBCs at birth also
had the highest retinal sensitivity, regardless of maternal DHA
status or supplementation group. However, dietary supple-
mentation of the diets of pregnant women with fish oil rich in
DHA from approximately 15 weeks of pregnancy until delivery
was associated with no observed enhancement of retinal de-
velopment of their infants, as measured shortly after birth by
scotopic ERG.
The role of dietary LCPUFAs in normal fetal and neonatal
visual development has been the focus of an increasing num-
ber of clinical studies over recent years. Most of these have
examined visual development using electrophysiological meth-
ods such as the VEP or behavioral methods such as the Teller
acuity card procedure. Few studies have used the ERG to
measure visual or, more precisely, retinal function, and all
were conducted in preterm infants.11,12,23,24 To the authors’
knowledge, this is the first published randomized clinical trial
to investigating term infant LCPUFA status and retinal develop-
ment by using the ERG.
In the present study, there were no significant differences
in Vmax or log  between infants in the maternal fish oil and
placebo supplementation groups. There were, however, a
number of significant correlations between infant DHA status
and maturity of the scotopic ERGs. Infants with higher retinal
sensitivity (based on lower log ) had higher DHA in umbilical
cord RBCs (%TFA) than did infants with lower retinal sensitiv-
ity. Moreover, the mean retinal sensitivity of infants in the
upper quartile for umbilical cord DHA was 0.6 log units higher
than that of infants in the lowest quartile for umbilical cord
DHA. These findings are in accordance with studies conducted
in preterm infants11,12 and indicate that increased DHA status
in blood is associated with enhanced sensitivity and maturity of
the rod photoreceptors.
The lack of a relationship between infant DHA status and
the parameter Vmax observed in the present study was similar
to findings reported by Birch et al.11 in their study of preterm
infants, in which they found that differences in the maximum
b-wave amplitude (Vmax) were marginal in comparison to the
differences in log  between infants fed LCPUFA-enhanced
diets and those fed standard formulas. Overall, results agree
well with full-field ERG data from slightly older infants.25 How-
ever, values obtained in the present study suggest that the
newborn retina may be more sensitive and have a larger Vmax
than predicted by the growth curve analysis of Fulton and
Hansen25 in which they used data from infants aged 23 days to
adults.25
The maximum combined ERG was recorded under scotopic
conditions in response to a bright white flash and elicited a
mixed rod and cone photoreceptor response. No significant
differences were observed between supplementation groups
in the implicit times or amplitudes of the maximum combined
ERG. Moreover, there were no significant correlations between
cord blood DHA status and birth and implicit times or ampli-
tudes of the maximum combined ERG. Our findings are again
comparable to those of Birch et al.11 who reported little dif-
ference in the amplitude of ERGs recorded to a maximum-
intensity white stimulus between infants fed diets differing in
LCPUFA content.
In the present study maternal fish oil supplementation dur-
ing pregnancy had no significant effect on DHA status or retinal
development of the neonate measured shortly after birth. It
was hypothesized that an increase in the amount of DHA
provided in the diet of women during pregnancy would elevate
the DHA status of their infants at term. If this were true,
increased levels of DHA available to the fetus during the period
of rapid brain and retinal growth might contribute to enhanced
retinal development. The lack of such a finding suggests that
both groups of fetuses obtained the required amounts of LCPU-
FAs from their mothers to meet the needs of the developing
retina. We found that infants in both the maternal supplemen-
tation and placebo groups had DHA status and ERG measures
within similar normal and acceptable ranges. It is interesting,
however, that, even within this healthy cohort of term infants,
functional differences in retinal sensitivity were identified be-
tween infants with higher levels of DHA in RBC and infants
with lower DHA levels. This suggests an association between
retinal maturation and DHA accretion by a mechanism that is
not based directly on maternal DHA status.
Preterm infants remain at an increased risk of LCPUFA
deficiency, because they do not receive the third trimester
intrauterine supply of DHA vital for brain and retinal develop-
ment. In addition, infants born of mothers of low socioeco-
nomic status and mothers with extremely poor diets may also
be at increased risk of LCPUFA deficiency and thus altered
retinal development. The authors are aware that our study
sample consisted of healthy mothers with relatively good di-
etary habits and that the results may have been different if
individuals from more deprived areas could have been in-
cluded.
Finally, although length of gestation was comparable be-
tween supplementation groups, infants in the upper quartiles
for DHA in plasma, both as %TFA and as a concentration, were
born at a significantly later gestational ages than were infants in
the lower quartiles. Specifically, the length of gestation for
infants in the upper quartile for plasma DHA was on average 8
days longer than that of infants in the lowest quartile. Helland
FIGURE 3. Log  for all infants according to quartiles of DHA in
umbilical cord RBCs (%TFA). The mean  SE of log  in infants in the
lowest (n  9), medium 1 (n  10), medium 2 (n  10), and highest
(n  9) quartiles was 0.62  0.14, 0.43  0.14, 0.18  0.15, and
0.06  0.16, respectively. Log  values are reversed so that more
sensitive retinas are plotted upward. Adult values appear for compar-
ison.
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et al.26 reported similar findings in a study of maternal LCPUFA
supplementation. In their study, women were supplemented
with either cod liver oil or corn oil from weeks 17 to 19 of
pregnancy until 3 months after delivery. The results demon-
strated longer gestational length, by an average of 7 days, in
those infants in the highest quartile for umbilical cord plasma
DHA concentration. Such findings are suggestive of a relation-
ship between higher plasma DHA status in the fetus and longer
gestation. It should be noted that we found no evidence for an
increase in membrane bound DHA in the RBCs, because the
length of gestation did not differ when infants were compared
based on DHA status in RBCs.
CONCLUSION
The present study provides additional evidence that the
LCPUFA DHA contributes to the development and function of
the visual system and supports the essentiality of this nutrient
during early fetal development. Maturation of the retina at birth
is enhanced proportionally with the DHA status in the RBCs of
umbilical cord blood. Maternal DHA supplementation during
pregnancy; however, did not result in any measurable benefits
to retinal development in this cohort of healthy term infants.
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